Products 357336-20-0
CAS 357336-20-0 appears in our catalog under these names: Brivaracetam, Brivaracetam, >95% (HPLC), Brivaracetam, >98.0%(HPLC)(T), Brivaracetam, 98%, Brivaracetam, min. 95 %, 50 mg. Offered by: Chemat Brand, Hubei YoungXin, TRC, Mikromol, GLPBio. Available pack sizes: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 250mg, 0,25g.
Brivaracetam is a non-proteinogenic amino acid derivative that is butanamide in which the pro-S hydrogen at position 2 is replaced by a (4R)-2-oxo-4-propylpyrrolidin-1-yl. Used for treatment of partial onset seizures related to epilepsy. It has a role as an anticonvulsant. It is a gamma-lactam and a non-proteinogenic amino acid derivative. It is functionally related to a L-alpha-aminobutyric acid.
Source: ChEBI
| Molecular formula | C11H20N2O2 |
|---|---|
| Molecular weight | 212.29 g/mol |
| IUPAC name | (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide |
| InChIKey | MSYKRHVOOPPJKU-BDAKNGLRSA-N |
| SMILES | CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N |
Computed by PubChem (NCBI)
Synonyms:
Brivaracetam, Briviact, (2s)-2-[(4r)-2-oxo-4-propylpyrrolidin-1-yl]butanamide, 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-, (2S)-2-((4R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide, brivaracetamum, 2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide, (S)-2-((R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide, Rikelta, Brivaracetam [USAN:INN]